Quick Answer
PROCEPT BioRobotics Corp reported Cash and Equivalents of $286.50 million for fiscal year 2025.
PROCEPT BioRobotics Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $286.50M | -14.1% |
| 2024 | $333.73M | +29.7% |
| 2023 | $257.22M | +15.9% |
| 2022 | $221.86M | -27.1% |
| 2021 | $304.32M | +203.9% |
| 2020 | $100.13M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $294.28M | +49.6% | -2.8% |
| June 30, 2025 | $302.72M | +41.4% | -4.3% |
| March 31, 2025 | $316.21M | +40.2% | -5.2% |
| December 31, 2024 | $333.73M | +29.7% | +69.6% |
| September 30, 2024 | $196.76M | -31.5% | -8.1% |
| June 30, 2024 | $214.09M | +43.0% | -5.1% |
| March 31, 2024 | $225.58M | +24.6% | -12.3% |
| December 31, 2023 | $257.22M | +15.9% | -10.4% |
- PROCEPT BioRobotics Corp showed a decrease of -14.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, PROCEPT BioRobotics Corp’s cash and equivalents has grown by 186.1% (from $100.13 million to $286.50 million).
- The most recent figure is from PROCEPT BioRobotics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: